Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav in Patients Previously Uncontrolled on a Beta-blocker
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2016
Price : $35 *
At a glance
- Drugs Travoprost/timolol (Primary) ; Travoprost/timolol (Primary) ; Beta-adrenergic receptor antagonists; Beta-adrenergic receptor antagonists
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 26 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Apr 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.